Hypertension in peripheral arterial disease

DL Clement, ML De Buyzere… - Current pharmaceutical …, 2004 - ingentaconnect.com
Peripheral arterial disease (PAD) of the lower limbs is associated with a high cardiovascular
morbidity and mortality. Intermittent claudication is the most common symptomatic …

Optimal risk factor modification and medical management of the patient with peripheral arterial disease

YW Chi, MR Jaff - Catheterization and Cardiovascular …, 2008 - Wiley Online Library
Peripheral arterial occlusive disease (PAD) is a highly prevalent atherosclerotic syndrome
associated with significant morbidity and mortality. It is defined by atherosclerotic obstruction …

Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events

G Coppola, S Novo - Archives of medical research, 2007 - Elsevier
Peripheral arterial disease (PAD) of the lower limbs is the third most important site of
atherosclerotic disease alongside coronary heart disease (CHD) and cerebrovascular …

Pharmacologic therapy for peripheral arterial disease and claudication

WR Hiatt - Journal of vascular surgery, 2002 - Elsevier
Peripheral arterial disease (PAD) is a common manifestation of systemic atherosclerosis that
is associated with a high risk of cardiovascular mortality and significant limitation in function …

Medical Therapy for Peripheral Artery Disease

ME Canonico, CN Hess, RK Rogers… - Current Cardiology …, 2024 - Springer
Comprehensive medical and non-medical management of PAD patients is crucial to
improving patient outcomes, mitigating symptoms, and reducing the risk of MACE and …

Contemporary management of peripheral arterial disease: I. Cardiovascular risk-factor modification.

HL Gornik, MA Creager - Cleveland Clinic journal of medicine, 2006 - europepmc.org
Patients with peripheral arterial disease (PAD) are at increased risk of myocardial infarction
or stroke, since multiple vascular beds, beyond the extremities, are likely to be affected by …

Management and Pharmacological Treatment of Peripheral Arterial Disease

SJ Leatham, KR Winckel… - Journal of Pharmacy …, 2024 - journals.sagepub.com
Background: Peripheral arterial disease (PAD) is a complex, heterogeneous condition that
has become a leading health concern globally. Peripheral arterial disease often co-exists …

Medical risk factor treatment in peripheral arterial disease. Need for further improvement.

A Alhadad, C Wictorsson, H Alhadad… - … Angiology: a Journal …, 2013 - europepmc.org
Aim Risk factors for development of peripheral arterial disease (PAD) are the same as for
atherosclerotic coronary or precerebral disease, and patients with PAD have a high …

Evidence-based medical management of peripheral artery disease

GH Bevan, KT White Solaru - Arteriosclerosis, thrombosis, and …, 2020 - Am Heart Assoc
Peripheral artery disease is an atherosclerotic disease of the lower extremities associated
with high cardiovascular mortality. Management of this condition may include lifestyle …

Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: A systematic review and meta-analysis

DG Kokkinidis, A Arfaras-Melainis… - Vascular …, 2020 - journals.sagepub.com
High-intensity statins are recommended for patients with peripheral artery disease (PAD).
Critical limb ischemia (CLI) is the most advanced presentation of PAD. The benefit of statins …